SYSTEMATIC REVIEW OF MEDICINAL BENEFITS OF CANNABIS SATIVA L. AND ITS IMPACT ON SOCIO-ECONOMIC DEVELOPMENT.

Authors

  • Sipho Goge Faculty of Natural Sciences, Mangosuthu University of Technology, P.O. Box 12363, Jacobs, 4026, Durban, KwaZulu- Natal, South Africa.
  • Karishma Singh Faculty of Natural Sciences, Mangosuthu University of Technology, P.O. Box 12363, Jacobs, 4026, Durban, KwaZulu- Natal, South Africa
  • Kuben Naidoo Faculty of Natural Sciences, Mangosuthu University of Technology, P.O. Box 12363, Jacobs, 4026, Durban, KwaZulu- Natal, South Africa

DOI:

https://doi.org/10.51168/sjhrafrica.v6i3.1564

Keywords:

Cannabis sativa, phytochemical, medicinal benefits, socio-economic development, chemotherapy, cannabinoid, pharmacology, tetrahydrocannabinol

Abstract

Medical Cannabis sativa inflorescence has gained popularity in recent years due to the therapeutic pharmacological characteristics of its components. Cannabis sativa L.-based drugs are effective in treating a variety of illnesses, including constipation, certain types of pain, epilepsy, and anxiety, among others. The therapeutic potential of medicinal Cannabis sativa has been established in different medical illnesses, such as sleep disorders, nausea, anorexia, emesis, pain, inflammation, neurodegenerative diseases, epilepsy, and cancer. Cannabis inflorescences contain a high concentration of secondary metabolites, primarily cannabinoids and terpenes.

Cannabis phytochemical components known as cannabidiol and 9-tetrahydrocannabinol have significant medicinal importance due to their effects on the central nervous system. Tetrahydrocannabinol is a pharmacological compound used to control and treat chemotherapy-induced nausea and vomiting, as well as to promote appetite. Tetrahydrocannabinol is the principal psychoactive constituent of Cannabis and one of at least 113 total cannabinoids identified in the plant.

The study aims to assess the medicinal benefit of Cannabis sativa and its impact on socioeconomic development. C. sativa has a wide-ranging impact on socioeconomic development, which has resulted in major economic gains in regions where it has been authorized. Projections indicate that the legal Cannabis market has generated significant tax income, which may be reinvested in community activities. Most clinical trials focused on the Western World, thus leaving a lack of data on how Cannabis sativa affects diverse African communities from lower socio-economic backgrounds. Future research must investigate the impact of cannabis production on poverty reduction and income inequality, as well as how benefits are distributed.

References

Adams, E.S. (2024). Just Don't Do It: Why Cannabis regulations are the reason Cannabis businesses are failing. Minnesota Legal Studies Research Paper 1: 24-16.

Akhtar, S (2021). Cannabinoid profile and regulatory compliance of non-scheduled cannabinoid-containing products in South Africa (Doctoral dissertation, University of Pretoria) 12: 2-18.

Alexander, S.P (2020). Barriers to the wider adoption of medicinal Cannabis. British Journal of Pain 14: 122-132.

Allen, J.A., Lee, Y.O., Woodlea, R., Malo, V.F. and Zitney, L.V (2023). Public education can be used to increase support for equity in cannabis policy. Cannabis 6: 76 -78.

Amode, N.S. and Jeetah, P., 2021. Paper production from Mauritian hemp fibers. Waste and Biomass Valorization 12: 1781-1802.

Anderson, D.M. and Rees, D.I., 2023. The public health effects of legalizing marijuana. Journal of Economic Literature 61: 86-143.

Arnold, J.C., Nation, T. and McGregor, I.S (2020) Prescribing medicinal Cannabis. Australian prescriber 5: 271 -343. https://doi: 10.1089/can.2019.0099305

Bakowska-Barczak, A., Esparza, Y., Kaur, H. and Popek, T., 2022. Industrial hemp-based dietary supplements and cosmetic products. In Industrial hemp 247-299. Academic Press.

Baral, P., Bagul, V. and Gajbhiye, S., 2020. Hemp seed oil for skin care (non-drug Cannabis sativa L): A review. World J. Pharm. Res 9: 2534-2556.

Boone, D.C (2021) Guild composition and the seasonal abundance of insects on hemp (Cannabis sativa L.) grown for fiber in Alabama (Master's thesis, Alabama State University) 28643761.

Borodovsky, J.T., Hasin, D.S., Shmulewitz, D., Walsh, C., Livne, O., Aharonovich, E., Struble, C.A., Habib, M.I. and Budney, A.J., 2024. Typical hits, grams, or joints: evaluating Cannabis survey measurement strategies for quantifying consumption. Cannabis and cannabinoid research 9: 646-658.

Bræmer, M.H. and Søgaard, T.F., 2023. “Do you need someone to share with?”: Exchange and demand sharing in social Cannabis Supply. Contemporary Drug Problems, 50: 46-62.

Brands, B., Di Ciano, P. and Mann, R.E (2021) Cannabis, impaired driving, and road safety: an overview of key questions and issues. Frontiers in Psychiatry 12: 641549.

Brewster, D. (2022) Cannabis Policy in Global Perspective. In Cultures of Cannabis Control 17-32. Bristol University Press.

Brewster, D. (2022). Problematizing Cannabis. In Cultures of Cannabis Control 66-85. Bristol University Press. https://doi.org/10.51952/9781529214987.ch004

Carvalho, A.C.A.D., Souza, G.A.D., Marqui, S.V.D., Guiguer, É.L., Araújo, A.C., Rubira, C.J., Goulart, R.D.A., Flato, U.A.P., Bueno, P.C.D.S., Buchaim, R.L. and Barbalho, S.M., 2020. Cannabis and cannabinoids on the inflammatory bowel diseases: going beyond misuse. International Journal of Molecular Sciences, 21: 2940.

Cerino, P., Buonerba, C., Cannazza, G., D'Auria, J., Ottoni, E., Fulgione, A., Di Stasio, A., Pierri, B. and Gallo, A., 2021. A review of hemp as food and nutritional supplement. Cannabis and cannabinoid research 6: 19 - 27.

Charitos, I.A., Gagliano-Candela, R., Santacroce, L. and Bottalico, L. (2021) Cannabis spread throughout the continents and its therapeutic use in history. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 21: 407- 417.

Cunningham, G.C (2021) The State and Cannabis: What is Success? A comparative analysis of Cannabis policy in The United States of America, Uruguay, and Canada. 2447.

Das, A., Hendershot, C.S., Husain, M.I., Knyahnytska, Y., Elsaid, S., Le Foll, B. and Kloiber, S., 2024. Perceptions, experiences, and patterns of Cannabis use in individuals with mood and anxiety disorders in the context of Cannabis legalization and medical Cannabis program in Canada. A Qualitative Study. Pharmacopsychiatry 57:141-151.

de Fátima dos Santos Sampaio, M., de Paiva, Y.B., Sampaio, T.B., Pereira, M.G. and Coimbra, N.C., 2024. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis, and Parkinson's disease and in comorbidity with psychiatric disorders. Basic & Clinical Pharmacology & Toxicology 134: 574-601.

Ekendahl, M., Månsson, J. and Karlsson, P., 2020. Cannabis use under prohibition-ism–the interplay between motives, contexts, and subjects. Drugs: Education, Prevention, and Policy 27: 368-376.

Feliciani, G., 2022. Cannabis Drug Development and the Controlled Substances Act. Duke J. Const. L. & Pub. Pol'y Sidebar 18: 153.

Ferreira, A.F.P., 2023. The economic and social potential of Cannabis Sativa L. for the sustainable development of a country: Brazil as a Case Study (Master's thesis, Universidade do Porto (Portugal)).

Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M.E., Pacula, R.L., Rehm, J., Room, R., van den Brink, W. and Hall, W., 2022. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. International Journal of Drug Policy 99:103381.

Garcia-Fuerte, J. and Garriott, W (2023) Greening the Green Rush: How Addressing the Environmental Impact of Cannabis can Enhance Social Equity and Remediate the Harms of the War on Drugs. Environmental Law, 53: 1-34.

Goodman, S., Wadsworth, E., Leos-Toro, C., Hammond, D. and International Cannabis policy study team (2020) Prevalence and forms of Cannabis use in legal vs. illegal recreational Cannabis markets. International Journal of Drug Policy 76: 102658. https://doi.org/10.1016/j.drugpo.2019.102658.

Gruben, V., Hyshka, E., Bonn, M., Cox, C., Gagnon, M., Guta, A., Jackman, M., Mercredi, J., Munga, A., Oscapella, E. and Strike, C (2024) Urgent and long overdue: legal reform and drug decriminalization in Canada. Facets, 9: 1-28.

Guido, P.C., Riva, N., Calle, G., Dell'Orso, M., Gatto, M., Sberna, N. and Schaiquevich, P., (2020) Medicinal Cannabis in Latin America: History, the current state of regulation, and the role of the pharmacist in a new clinical experience with cannabidiol oil. Journal of the American Pharmacists Association 60: 212-215.

Gwala, R.S., 2023. The Legalisation of Cannabis in South Africa: Proposing an Economic Value Chain Model for South Africa. In Rapid Innovation and Development in the Global Cannabis Market. IGI Global 10: 98-122 DOI: 10.4018/978-1-6684-6346-8.ch006

Halladay, J.E., MacKillop, J., Munn, C., Jack, S.M. and Georgiades, K (2020) Cannabis use as a risk factor for depression, anxiety, and suicidality: Epidemiological associations and implications for nurses. Journal of Addictions Nursing 31: 92-101.

Hammond, C.J., Chaney, A., Hendrickson, B. and Sharma, P. (2020) Cannabis use among US adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates. International Review of Psychiatry 32: 221- 234.

Hammond, D., Goodman, S., Wadsworth, E., Rynard, V., Boudreau, C. and Hall, W (2020) Evaluating the impacts of cannabis legalization: the International Cannabis Policy Study. International Journal of Drug Policy 77: 102698 https://doi.org/10.1016/j.drugpo.2020.102698

Huberfeld, N., 2021. Health Equity, Federalism, and Cannabis Policy. Bul Rev 101: 897-913.

Jain, S., Cloud, G.W., Gordon, A.M., Lam, A.W., Vakharia, R.M., Saleh, A. and Razi, A.E., (2024) Cannabis use disorder is associated with longer in-hospital lengths of stay, higher rates of medical complications, and costs of care following primary 1-to 2-level lumbar fusion. Global Spine Journal 14: 67- 73.

Kalayasiri, R. and Boonthae, S (2023) Trends of Cannabis use and related harms before and after legalization for recreational purposes in a developing country in Asia. BMC Public Health 23: 911 https://doi.org/10.1186/s12889-023-15883-6

Kavousi, P., Giamo, T., Arnold, G., Alliende, M., Huynh, E., Lea, J., Lucine, R., Tillett Miller, A., Webre, A., Yee, A., and Champagne‐Zamora, A (2022) What do we know about opportunities and challenges for localities from Cannabis legalization? Review of Policy Research 39: 143-169.

Kelly, E.C. and Formosa, M.L (2020) The economic and cultural importance of cannabis production in a rural place. Journal of Rural Studies 75: 1- 8.

Kilmer, B., Caulkins, J.P., Kilborn, M., Priest, M. and Warren, K.M (2021) Cannabis legalization and social equity: some opportunities, puzzles, and trade-offs. Bul Rev 101: 1003 -1040.

Kitchen, C., Kabba, J.A. and Fang, Y (2022) Status and impacts of recreational and medicinal cannabis policies in Africa: A systematic review and thematic analysis of published and “gray” literature. Cannabis and Cannabinoid Research 7: 239- 261.

Kotiranta, S., Pihlava, J.M., Kotilainen, T. and Palonen, P. (2024) The morphology, inflorescence yield, and secondary metabolite accumulation in hemp-type Cannabis sativa can be influenced by the R: FR ratio or the amount of short wavelength radiation in a spectrum. Industrial Crops and Products 208: 117772 https://doi.org/10.1016/j.indcrop.2023.117772

Kruger, D.J. and Kruger, J.S., 2023. Consumer experiences with delta-8-THC: medical use, pharmaceutical substitution, and comparisons with delta-9-THC. Cannabis and cannabinoid research 8:166-173.

Kruger, D.J., Kruger, J.S. and Collins, R.L (2020) Cannabis enthusiasts’ knowledge of medical treatment effectiveness and increased risks from cannabis use. American Journal of Health Promotion 34: 436- 439.

Kumar, P., Mahato, D.K., Kamle, M., Borah, R., Sharma, B., Pandhi, S., Tripathi, V., Yadav, H.S., Devi, S., Patil, U. and Xiao, J (2021) Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview. Phytotherapy Research 35: 6010- 6029.

Kumar, A., Kindig, K., Rao, S., Zaki, A.M., Basak, S., Sansom, M.S., Biggin, P.C. and Chakrapani, S., 2022. Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs. Nature Communications, 13: 4862.

Laqueur, H., Rivera-Aguirre, A., Shev, A., Castillo-Carniglia, A., Rudolph, K.E., Ramirez, J., Martins, S.S. and Cerdá, M (2020) The impact of Cannabis legalization in Uruguay on adolescent cannabis use. International Journal of Drug Policy 80: 102748 https://doi.org/10.1016/j.drugpo.2020.102748

Lawson, L., Degenstein, L.M., Bates, B., Chute, W., King, D. and Dolez, P.I., 2022. Cellulose textiles from hemp biomass: Opportunities and challenges. Sustainability 14:15337.

Legare, C.A., Raup-Konsavage, W.M. and Vrana, K.E (2022) Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacology 107: 131-149.

Leinen, Z.J., Mohan, R., Premadasa, L.S., Acharya, A., Mohan, M. and Byrareddy, S.N., (2023) Therapeutic potential of Cannabis: a comprehensive review of current and future applications. Biomedicines 11: 2630 https://doi.org/10.3390/biomedicines11102630

Malabadi, R.B., Kolkar, K.P. and Chalannavar, R.K (2023) Δ9-Tetrahydrocannabinol (THC): The major psychoactive component is of botanical origin. International Journal of Innovation Scientific Research and Review 5: 4177- 4184.

Malabadi, R.B., Mammadova, S.S., Kolkar, K.P., Sadiya, M.R., Chalannavar, R.K. and Coronado, K.V.C (2024) Cannabis sativa: A therapeutic medicinal plant-global marketing updates. World Journal of Biology Pharmacy and Health Sciences 17: 170-183.

Malcolm, B. (2020) Decriminalization and medicalization of cannabis: Implications of the Caribbean experience for global social work practice. In The Routledge Handbook of Social Work and Addictive Behaviors 497-512. Routledge.

Manu, E., Douglas, M., Ntsaba, M.J. and Tarkang, E.E (2021) Perspectives of illicit marijuana growers and traders on commercial legalization of marijuana in South Africa: considerations for policy formulation. Substance Abuse Treatment, Prevention, and Policy 16: 54- 58.

Mariz, J., Guise, C., Silva, T.L., Rodrigues, L. and Silva, C.J., 2024. Hemp: From Field to Fiber—A Review. Textiles 4:165-182.

Martínez, B., Bernat-Maso, E. and Gil, L., 2023. Applications and properties of hemp stalk-based insulating biomaterials for buildings. Materials 16:3245.

Maule, W.J., 2022. The therapeutic use of cannabis in South Africa: panacea or scourge? The Journal of Medical Laboratory Science and Technology of South Africa 4: 99-107.

McPartland, J.M. and Small, E (2020) A classification of endangered high-THC cannabis (Cannabis sativa subsp. indica) domesticates and their wild relatives. PhytoKeys 144: 81- 92.

Mogoro, B.M. and Odeku, K.O (2020) Paradigm shift from criminalization to constitutional legal protection for the use of Cannabis in South Africa: Issues and Perspectives. African Renaissance 17: 1744- 2532.

Moriconi, M. and Peris, C.A (2022) Cultivating Cannabis in a Paraguayan nature reserve: Incentives and moral justification for breaking the law. Trends in Organized Crime 1-22. https://dx.doi.org/10.1007/s12117-022-09464-z.

Mortimer, T.L., Mabin, T. and Engelbrecht, A. (2019) Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting. Future Oncology 15: 1035-1049.

Nkosi, P.I., 2021. Dagga and data: Cannabis, race, and policing in mid-century South Africa, 1932–1960. The Social History of Alcohol and Drugs, 35: 232-259.

Orenstein, D.G. and Glantz, S.A (2020) Cannabis legalization in state legislatures: Public health opportunity and risk. Marquette Law Review 103: 1313- 1400.

Ortiz, Y.T., McMahon, L.R. and Wilkerson, J.L (2022) Medicinal Cannabis and central nervous system disorders. Frontiers in Pharmacology 13: 881810 https://doi.org/10.3389/fphar.2022.881810

Pacula, R.L., Pessar, S., Zhu, J., Kritikos, A. and Smart, R. (2022) Federal regulation of cannabis for public health in the United States. Schaeffer Center White Paper Series 213: 810- 8554.

Parvez, A.M., Lewis, J.D. and Afzal, M.T (2021) Potential of industrial hemp (Cannabis sativa L.) for bioenergy production in Canada: Status, challenges, and outlook. Renewable and Sustainable Energy Reviews 141:110784 https://doi.org/10.1016/j.rser.2021.110784

Queirolo, R (2020) Uruguay: The first country to legalize Cannabis. In Legalizing Cannabis, pp 116-130. Routledge.

Rehman, M., Fahad, S., Du, G., Cheng, X., Yang, Y., Tang, K., Liu, L., Liu, F.H. and Deng, G (2021) Evaluation of hemp (Cannabis sativa L.) as an industrial crop: a review. Environmental Science and Pollution Research 28: 52832-52843.

Robinson, Z. and Rushin, S (2022) The law enforcement lobby. Minn. L. Rev 107: 1965 – 2037.

Sahu, T., Ratre, Y.K., Chauhan, S., Bhaskar, L.V.K.S., Nair, M.P. and Verma, H.K (2021) Nanotechnology-based drug delivery system: Current strategies and emerging therapeutic potential for medical science. Journal of Drug Delivery Science and Technology 63: 102487 https://doi.org/10.1016/j.jddst.2021.102487

Sarma, N.D., Waye, A., ElSohly, M.A., Brown, P.N., Elzinga, S., Johnson, H.E., Marles, R.J., Melanson, J.E., Russo, E., Deyton, L. and Hudalla, C (2020) Cannabis inflorescence for medical purposes: USP considerations for quality attributes. Journal of Natural Products 83: 1334-1351.

Scher, B.D., Neufeld, S.D., Butler, A., Bonn, M., Zakimi, N., Farrell, J. and Greer, A. (2023) “Criminalization Causes the Stigma”: perspectives from people who use drugs. Contemporary Drug Problems 50: 402-425.

Simard, B.J., Padon, A.A., Silver, L.D., Avalos, L.A., Soroosh, A.J. and Young-Wolff, K.C., (2024) Racial, ethnic, and neighborhood socioeconomic disparities in local Cannabis retail policy in California. International Journal of Drug Policy 131: 104542 - https://doi.org/10.1016/j.drugpo.2024.104542

Somboonwit, C., Rutenburg, D., Oxner, A. and Menezes, L., 2024. Marijuana and HIV. In Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century (pp. 127-142). Cham: Springer International Publishing.

Stanciu, C.N., Brunette, M.F., Teja, N. and Budney, A.J., 2021. Evidence for use of cannabinoids in mood disorders, anxiety disorders, and PTSD: a systematic review. Psychiatric Services 72: 429-436.

Sukpiriyagul, A., Chartchaiyarerk, R., Tabtipwon, P., Smanchat, B., Prommas, S., Bhamarapravatana, K. and Suwannarurk, K., 2023. Oral Tetrahydrocannabinol (THC): Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial. International Journal of Women's Health 1345-1352.

Sun, X (2023) Research progress on Cannabinoids in Cannabis (Cannabis sativa L.) in China. Molecules 28: 3806 - https://doi.org/10.3390/molecules28093806

Tănase Apetroaei, V., Pricop, E.M., Istrati, D.I. and Vizireanu, C., 2024. Hemp Seeds (Cannabis sativa L.) as a Valuable Source of Natural Ingredients for Functional Foods—A Review. Molecules 29: 2097.

Taylor, H., 2021. Policy designs for social equity in the context of legal Cannabis lessons from the US states (Doctoral dissertation, Central European University).

The sane, R.M (2024) Envisaging challenges for the emerging medicinal Cannabis sector in Lesotho. Journal of Cannabis Research 6: 23 – 28.

Vilakazi, M.B., 2023. The Industrialization of Cannabis in South Africa: A State-Led Case for High-Powered Redistribution. In Rapid Innovation and Development in the Global Cannabis Market (pp. 262-280). IGI Global.

Warnick, B.J., Kier, A.S., LaFrance, E.M. and Cuttler, C., 2021. Head in the clouds? Cannabis users' creativity in new venture ideation depends on their entrepreneurial passion and experience. Journal of Business Venturing 36:106088.

Weiser, S., 2023. learning from past mistakes: how congress should model a proposed future mass expungement for marijuana convictions. Michigan State Law Review, 2023(4).

Wu, G., Li, Y., and Lang, X.E (2022) Effects of recreational marijuana legalization on clearance rates for violent crimes: Evidence from Oregon. International Journal of Drug Policy 100: 103528 - https://doi.org/10.1016/j.drugpo.2021.103528

www.info@cleanleaf.com (accessed on 17 August 2024).

Yadav, S.P.S., Kafle, M., Ghimire, N.P., Shah, N.K., Dahal, P. and Pokhrel, S (2023) An overview of phytochemical constituents and pharmacological implications of Cannabis sativa L. Journal of Herbal Medicine 42:100798 - https://doi.org/10.1016/j.hermed.2023.100798

Zamengo, L., Frison, G., Zwitser, G., Salomone, A. and Freeman, T.P., 2020. Cannabis knowledge and implications for health: Considerations regarding the legalization of non-medical cannabis. Medicine, Science and the Law 60: 309-314.

Zhao, H., Xiong, H. and Chen, J., 2021. Regional comparison and strategy recommendations of industrial hemp in China based on a SWOT analysis. Sustainability 13: 6419 https://doi.org/10.3390/su13116419

Downloads

Published

2025-03-17

How to Cite

Goge, S., Singh, K. ., & Naidoo, K. . (2025). SYSTEMATIC REVIEW OF MEDICINAL BENEFITS OF CANNABIS SATIVA L. AND ITS IMPACT ON SOCIO-ECONOMIC DEVELOPMENT. Student’s Journal of Health Research Africa, 6(3), 12. https://doi.org/10.51168/sjhrafrica.v6i3.1564

Issue

Section

Section of Environmental sciences Research